DIAGNOS Finalizes Successful Non-Brokered Private Placement

Author: Olivia Taylor Updated: 09-05-2025 04:00 PM

DIAGNOS Successfully Completes Private Placement

Diagnos Inc. (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) has effectively concluded a non-brokered private placement, initially announced recently. This strategic move resulted in the issuance of 10 units, each priced at $10,000, attracting a total of $100,000 in gross proceeds.

Structure of the Private Placement

Details of Each Unit

Notably, each unit consists of one unsecured convertible debenture and stock warrants. The debentures, valued at $10,000 each, have a 12-month term ending the following year and carry an interest rate of 10% payable every six months. Shareholders have the option to convert these debentures into common shares at a price of $0.28 each during the term.

Additionally, each warrant allows the holder to purchase a common share at $0.40 anytime during the same period.

Intended Use of Funds

Funds raised from this private placement are earmarked primarily for product development and the commercialization of AI-driven screening services. Further allocations include general administrative expenses, highlighting the corporation's commitment to enhancing its operational capabilities.

Director Participation and Compliance

Intriguingly, the subscription of these units was made by one of the corporation's directors, classified as a related party under relevant laws. The transaction has received board approval following thorough evaluation to confirm that it aligns with the interests of DIAGNOS and its shareholders. Importantly, the participation of this director does not exceed 25% of the corporation's market capitalization, which allows the transaction to qualify for certain exemptions.

Regulatory Considerations

All securities issued through this private placement are subject to a statutory hold period, concluding in early January of the following year. The entire transaction will also require completion of all necessary approvals, including from the TSX Venture Exchange.

About DIAGNOS

DIAGNOS is a publicly traded corporation focused on the early detection of critical health issues, especially concerning eye-related conditions. By employing advanced Artificial Intelligence technology, the company strives to provide healthcare professionals with improved diagnostic tools, thereby enhancing patient outcomes globally.

For further information, please visit the official DIAGNOS website for updates and insights.

Frequently Asked Questions

What is the purpose of the private placement by DIAGNOS?

The fund raised will support product development, commercialization of AI-based services, and cover general expenses.

Who is participating in the private placement?

One director of DIAGNOS has subscribed to the units, considered a related party in the context of the placement.

What are the terms of the convertible debentures?

The debentures have a 12-month term, an interest rate of 10%, and can be converted into common shares at $0.28 each.

When does the statutory hold period end?

The hold period for the securities issued in the private placement ends in early January of the following year.

What is DIAGNOS's main service focus?

DIAGNOS focuses on early detection of eye-related health problems through advanced AI technology to improve diagnostic accuracy.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.